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Introduction
Most clinicians are faced with patients suffering from acute pain after surgical treatment. In order to treat postoperative pain, Crile developed the concept of preemptive analgesia in 1913. [1] Preemptive analgesia has been shown that analgesics given before the injury decrease central sensitization and therefore postoperative pain very significantly in comparison to the analgesics given after the injury. The effect of the preemptive analgesia is to prevent or reduce the development of any "memory"of the pain stimulus in the nervous system. [2] Dexketoprofen trometamol (DT) is a non-steroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory and antipyretic actions belonging to the 2-arylpropionic acid family. Dexketoprofen is the S (+) enantiomer of the racemic compound ketoprofen. [3] DT that has demonstrated a good analgesic efficacy and a good safety profile in different acute and chronic painful conditions administered by oral route. [4] [5] [6] [7] Jiménez et al. [8] reported that oral DT administration is effective in reducing pain after impacted mandibular third molar removal better than ibuprofen.
A parenteral formulation of DT for intravenous and intramuscular administration has been developed and recently marketed, showing good results in both efficacy and safety evaluations in renal colic [9] and in postoperative pain. [3, 10] The objective of this study was to compare the efficacy of intravenous (IV) DT given before surgical extraction of an impacted mandibular third molar under local anesthesia.
Materials and Methods
This study was carried out in the Department of Oral and Maxillofacial Surgery of the Faculty of Dentistry of Ege University, following the approval of the Ethics Committe of Ege University Faculty of Medicine. All subjects were informed of the possible risks of oral surgery and treatments used. Each patient accepted and signed an informed consent form. This prospective, placebo-controlled, randomized study compared the effects of IV DT and placebo on postoperative pain control after third molar surgery. All patients were of American Society of Anesthesiologists (ASA) status I or II over 18 years old and had bilateral impacted mandibular third molars based on orthopantomogram evidence.
Patients who used analgesics for other reasons in the past 24 hours, had drug allergy, hepatic insufficiency, renal insufficiency, bleeding diathesis or gastrointestinal system complaints and pregnant patients were excluded from the study.
Study design
This was a crossover within-subject study and the patient would be pretreated with 0.9% isotonic saline solution or 50 mg IV DT for the bilateral third molar surgeries in the same patient according to a randomization schedule.
In groups placebo and DT, randomly selected drugs administered consecutively to same 20 patient population group before the third molar teeth extractions which had been made 15 days apart. The drugs were disvolved in 100 ml of 0.9% isotonic saline solution and then administered via IV infusion in 15 min. After 15 min, the surgeon gave an inferior dental nerve block with local anesthetic 2% lidocaine with 1:100000 epinephrine for the regional anesthesia. The surgical removal of the impacted mandibular third molar was then completed with a standardized technique by the same surgeon.
Demographics of the patients were recorded and a total number of 40 observations were performed.
Assessments
During the postoperative assessment of the patients, the level of pain was determined by using the Verbal Rating Scale (VRS) (0= no pain, 5= worst possible pain). Pain perception was recorded at 15 min, 30 min and 1, 2, 4, 6, 12, 24 hour when the time of incision was considered the baseline. Moreover, the duration of the operation, the time to first analgesic requirement use , additional analgesic need of patients, patient and doctor satisfaction (0= none,1= moderate, 2= good 3= perfect), side effects such as nausea, vomiting, allergic reactions, were also determined. Patients with moderate postoperative pain (VRS ≥3) were given Diclophenac Na 75mg oral.
Statistics
All analyses were performed by SPSS version 15.0 software package. Changes in VRS pain scores were assessed by Wilcoxon signed-rank test, the global assessments were assessed by Chi-square statistic. A value of p<0.05 was considered as significant.
Results
In the present study, a total number of 40 observations were carried out in 20 patients. There were no statistically significant differences in patient demographics and the duration of the operation between two groups (Table 1) .
During the first 12 hours, the VRS values in DT Group were significantly lower than those of Placebo Group patients (p<0.05) (Figure 1 ). While the highest VRS value was determined to be during the 2nd hour in Placebo Group (5±1.6), in DT Group patients, it was the highest during the 4th hour (2.9±2.1). In Placebo Group, the first analgesic requirement time was significantly earlier than that in Group DT (p<0.05). Additional analgesic need of Placebo Group patients were significantly greater, when compared with the analgesic need of Group DT Group patients (p<0.05). Additional analgesic need occurred in 19 patients in Placebo Group, and 9 patients in DT Group . Among the DT Group patients, patient and physician satisfaction was greater, which was statistically significant (p<0.05) ( Table 2 ).
Discussion
The surgical extraction of impacted mandibular third molars induces acute moderate to severe pain, and has been used as an excellent clinical trial model for pain studies. ferences between groups in pain intensity measured by VRS at 12 hour postsurgery. However, it seems that this difference evaluated by itself does not have clinical significance for pain relief because of its subjective assessment; however, we consider the clear difference in analgesic consumption after treatment to be clinically relevant.
The study is show that, in patients undergoing removal of an impacted mandibular third molar, treatment with preemptive DT resulted in an important reduction in consumption of postoperative analgesics.
Conclusion
DT is more effective than placebo for using as preemptive analgesia for acute postoperative pain control in patients underwent removal of an impacted mandibular third molar.
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Many factors in the postoperative pain resulting from surgical extraction relate to the peripheral inflammatory reaction initiated by surgical trauma. NSAID's are among the most widely used medications in the word because of their demonstrated efficacy in reducing pain and inflammation. By decreasing prosthoglandin production, NSAID's attenuate the response of the peripheral and central components of the nervous system to noxious stimuli.
Pre-emptive analgesia may be defined as an antinociceptive treatment that prevents establishment of altered central processing of afferent input from sites of injury. [12] This property makes NSAID's ideal drugs to use in a preemptive analgesia.Therefore NSAID's have been reported to be effective for the pain after surgical extraction [13, 14] and have been used for the effectiveness of preemptive analgesia concerning administration time in numerous reports. [12, 15] Pre-or postoperative administration of 550 mg naproxen or 1.000 mg diflunisal orally produces good pain relief after surgical removal of impacted third molars. However, no significant differences were found in either study about pain relief between the pre-and postoperative approaches. [16, 17] A study using preemptive analgesia showed that tramadol 50 mg IV is more effective than oral tramadol 50 mg in relieving pain after third molar surgery. [18] Another study demonstrated that ketorolac 30 mg IV produces beter preventive analgesic efficacy than tramadol 50 mg IV when administered preoperatively in third molar surgery. [19] Although there have been some studies evaluating the efficacy of dexketoprofen for dental pain [8, 20] our study is the first clinical investigation to examine the analgesic effects of IV DT for preemptive analgesia for third molar surgery.
This study demonstrated that IV administration of DT showed clear differences in the need for postoperative analgesic consumption compared with the group receiving placebo. We found that only 9 patients in DT group needed medication within 12 hour after surgery compared with 19 patients from placebo group. We found statistically significant dif-
